Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Recalls

Drug Recalls in Canada

Medication recalls and safety alerts, pulled directly from Health Canada's Recalls and Safety Alerts database — the same source your pharmacy checks.

Last synced Nov 19, 2026, 9:00 a.m.

1057 results

PegLyte Powder

PegLyte Powder: Affected lots may contain foreign matter

Type III2026-11-17

Low health risk

Taro-Candesartan tablets

TARO-CANDESARTAN: affected lots may contain Esomeprazole 20mg capsules

Type II2026-11-16

Moderate health risk

SECARIS NASAL GEL

SECARIS NASAL GEL: Affected lot may contain foreign matter

Type II2026-11-13

Moderate health risk

Unauthorized peptides (injectable and capsule format)

Health Canada warns about unauthorized peptides, including contaminated injectable peptides sold by Sage & Summit Wellness Co. in Ottawa, ON

2026-11-12

PDP-DIPHENHYDRAMINE

PDP-DIPHENHYDRAMINE 25 MG and 50 MG CAPSULES: Out-of-specification (Impurity)

Type II2026-11-09

Moderate health risk

Unauthorized injectable peptide and non-peptide drugs

Health Canada warns about contaminated unauthorized injectable peptides and non-peptide drugs

2026-11-06

ANTICOAGULANT SODIUM CITRATE SOLUTION, USP

ANTICOAGULANT SODIUM CITRATE SOLUTION, USP 4g/100mL and Potential Bag Leaks

2026-11-03

Cyclophosphamide for Injection USP

Cyclophosphamide for Injection USP: Presence of particulate matter

Type I2026-10-30

Highest health risk

Femyso Mifepristone 200mg / Misoprostol 200 mcg tablet

Femyso: Affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each.

Type II2026-10-21

Moderate health risk

Dantrium Intravenous (Dantrolene sodium for injection)

Dantrium Intravenous (Dantrolene sodium for injection): Presence of particulate matter

Type I2026-10-19

Highest health risk

Aleve

Aleve 200 mg caplets: Recalled from wholesalers (Distribution Error)

Type III2026-10-15

Low health risk

Claritin Allergy Tablets

Claritin Allergy Tablets 10 mg: Recalled from wholesalers (Distribution Error)

Type III2026-10-15

Low health risk

PMS-Carvedilol

PMS-Carvedilol 25 mg Tablets: Out-of-specification (Impurity)

Type II2026-10-06

Moderate health risk

PMS-FAMPRIDINE

PMS-FAMPRIDINE 10 mg Tablet: Affected lot may contain foreign material particles.

Type II2026-10-06

Moderate health risk

Carvedilol

Carvedilol 25 mg Tablets: Out-of-specification (Impurity)

Type II2026-10-06

Moderate health risk

CARVEDILOL

Carvedilol 25 mg Tablets: Out-of-specification (Impurity)

Type II2026-10-05

Moderate health risk

PDP-DIPHENHYDRAMINE

PDP-DIPHENHYDRAMINE 25 MG CAPSULE: Out-of-specification (Impurity)

Type II2026-10-05

Moderate health risk

Apo-Semaglutide Injection

Apo-Semaglutide Injection : Incorrect dose display

Type II2026-09-24

Moderate health risk

Novo-Gesic Forte 500 mg tablets (acetaminophen)

Generic acetaminophen by Teva recalled because it may contain foreign material

Type I2026-09-10

Highest health risk

JAMP Temozolomide

JAMP Temozolomide: Out-of-Specification (Assay)

Type II2026-08-31

Moderate health risk

Apo-Semaglutide

Apo-Semaglutide Injection : Incorrect dose display

Type II2026-08-27

Moderate health risk

Semaglutide Injection

Semaglutide Injection : Out-of-Specification (Impurity)

Type II2026-08-26

Moderate health risk

Twins Herbal Idakole and Twins Herbal Pelorie

Twins Herbal Products: Undeclared prescription drug (sildenafil)

Type I2026-08-25

Highest health risk

BONKY Injection, 1 mcg/mL Calcitriol

Importation of South Korean-Authorized BONKY Injection, 1 mcg/mL Calcitriol, due to the Current Shortage of Canadian-Authorized Calcitriol Injection USP, 1 mcg/mL

2026-08-24

CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE

CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE: The level of the degradation product Benzaldehyde may be out of specification in the affected lots.

Type III2026-08-19

Low health risk

Various unauthorized health products, including prescription drugs

Unauthorized drugs seized from Rabais 4Saisons Inc. in Montreal, QC, may pose serious health risks

2026-08-18

Lactated Ringer's Injection USP

Lactated Ringer's Injection USP: Presence of Particulate Matter

Type I2026-08-17

Highest health risk

Teva-Pregabalin 150 mg capsules

Two lots of Teva-Pregabalin 150 mg capsules recalled due to cross-contamination with the drug sertraline

Type I2026-08-15

Highest health risk

Various unauthorized—including counterfeit—injectable health products

Unauthorized injectable health products sold online and seized from Dyosa Beauty & Wellness Lounge in Hamilton, ON, may pose serious health risks

2026-08-13

pms-IRBESARTAN 150 mg Tablet

pms-IRBESARTAN: Affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.

Type II2026-08-12

Moderate health risk

Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice. See our guides for what to do if your medication is recalled.